{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:58Z","timestamp":1791216538735,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.det.2010.03.007","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T06:01:09Z","timestamp":1275026469000},"page":"489-499","source":"Crossref","is-referenced-by-count":11,"title":["Innovative Management of Lupus Erythematosus"],"prefix":"10.1016","volume":"28","author":[{"given":"Haydee M.","family":"Knott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Dar\u00edo","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2010.03.007_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.det.2010.03.007_bib2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1610-0387.2007.06554.x","article-title":"Clinical manifestations of cutaneous lupus erythematosus","volume":"5","author":"Kuhn","year":"2007","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.det.2010.03.007_bib3","unstructured":"Werth VP. New approaches to cutaneous lupus. Dermatology focus, DF Clinical Symposia: Proceedings 2009-Part II, Summer 2009 Vol. 28 NO.2. Naples, Florida, January 28--February 1, 2009."},{"key":"10.1016\/j.det.2010.03.007_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yadr.2006.09.009","article-title":"Issues and advances in the management and pathogenesis of cutaneous lupus erythematosus","volume":"22","author":"Pelle","year":"2006","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.det.2010.03.007_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002954.pub2","article-title":"Drugs for discoid lupus erythematosus","volume":"4","author":"Jessop","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.det.2010.03.007_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00403-008-0894-6","article-title":"Topical calcineurin inhibitors in cutaneous lupus erythematosus","volume":"301","author":"S\u00e1rdy","year":"2009","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"10.1016\/j.det.2010.03.007_bib7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2230.2008.03138.x","article-title":"Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study","volume":"34","author":"Barikbin","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2010.03.007_bib8","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/rheumatology\/kei093","article-title":"Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus","volume":"44","author":"Tlacuilo-Parra","year":"2005","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.det.2010.03.007_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2230.2009.03351.x","article-title":"Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study","volume":"35","author":"Madan","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2010.03.007_bib10","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1365-2133.2009.09330.x","article-title":"A randomized controlled trial of R-salbutamol for topical treatment of discoid lupus erythematosus","volume":"161","author":"Jemec","year":"2009","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.det.2010.03.007_bib11","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archderm.143.12.1589","article-title":"Discoid and subacute lupus erythematosus treated with 0.5% R-salbutamol cream","volume":"143","author":"Wulf","year":"2007","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.007_bib13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2230.2008.03006.x","article-title":"Systematic administration of chloroquine in discoid lupus erythematosus reduces skin lesions via inhibition of angiogenesis","volume":"34","author":"Lesiak","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"3-4","key":"10.1016\/j.det.2010.03.007_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4067\/S0716-97602002000300008","article-title":"Effects of betamethasone, sulindac and quinacrine drugs on the inflammatory neoangiogenesis response induced by polyurethane sponge implanted in mouse","volume":"35","author":"Illanes","year":"2002","journal-title":"Biol Res"},{"key":"10.1016\/j.det.2010.03.007_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/0961203308101714","article-title":"Treatment of lupus skin involvement with quinacrine and hydroxychloroquine","volume":"18","author":"Cavazzana","year":"2009","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.det.2010.03.007_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archdermatol.2009.30","article-title":"Lenalidomide for the treatment of resistant discoid lupus erythematosus","volume":"145","author":"Shah","year":"2009","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.007_bib17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1191\/0961203303lu1029oa","article-title":"CTLA4Ig: a novel inhibitor of costimulation","volume":"13","author":"Dall'Era","year":"2004","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.det.2010.03.007_bib18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2125.2009.03502.x","article-title":"Abatacept","volume":"68","author":"Dubois","year":"2009","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.det.2010.03.007_bib19","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archderm.143.7.873","article-title":"Efalizumab in the treatment of discoid lupus erythematosus","volume":"143","author":"Usmani","year":"2007","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.007_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00105-009-1767-4","volume":"61","author":"Booken","year":"2010","journal-title":"Hautlarzt"},{"key":"10.1016\/j.det.2010.03.007_bib21","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1046\/j.1365-2133.1999.03203.x","article-title":"Cutaneous lupus erythematosus\u2014treatment with pulsed dye laser","volume":"141","author":"Raulin","year":"1999","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.007_bib22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaad.2008.11.904","article-title":"Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus","volume":"60","author":"Erceg","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2010.03.007_bib23","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.revmed.2009.01.021","article-title":"Photosensitivity in lupus erythematosus","volume":"30","author":"Bens","year":"2009","journal-title":"Rev Med Interne"},{"issue":"6","key":"10.1016\/j.det.2010.03.007_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/0961203308089440","article-title":"Triple need for photoprotection in lupus erythematosus","volume":"17","author":"Obermoser","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.det.2010.03.007_bib25","first-page":"291","article-title":"Established and novel treatments for lupus","volume":"26","author":"Vasudevan","year":"2009","journal-title":"J Muscoskel Med"},{"key":"10.1016\/j.det.2010.03.007_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1440-0960.2006.00217.x","article-title":"Cutaneous lupus erythematosus: a personal approach to management","volume":"47","author":"Callen","year":"2006","journal-title":"Australas J\u00a0Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.007_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/berh.2001.0224","article-title":"Management of skin disease in patients with lupus erythematosus","volume":"16","author":"Callen","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.007_bib28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/00128071-200304060-00002","article-title":"Thalidomide in cutaneous lupus erythematosus","volume":"4","author":"Pelle","year":"2003","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.007_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-4632.2007.03333.x","article-title":"Leflunomide in subacute cutaneous lupus erythematosus\u2014two sides of a coin","volume":"47","author":"Suess","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2010.03.007_bib30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2004.01.044","article-title":"Pimecrolimus 1% cream for cutaneous lupus erythematosus","volume":"51","author":"Kreuter","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2010.03.007_bib31","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/keh325","article-title":"Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative","volume":"43","author":"Lampropoulus","year":"2004","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.det.2010.03.007_bib32","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2133.2007.07826.x","article-title":"Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy","volume":"156","author":"Kreuter","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.007_bib33","first-page":"393","article-title":"Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil","volume":"23","author":"Pisoni","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.007_bib34","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10067-006-0222-5","article-title":"Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative","volume":"26","author":"Lampropoulos","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.007_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1440-0960.2009.00539.x","article-title":"Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab","volume":"50","author":"Kieu","year":"2009","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.det.2010.03.007_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00228-007-0421-2","article-title":"Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation","volume":"64","author":"Tzellos","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.det.2010.03.007_bib37","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ncprheum0855","article-title":"Control of autoimmune diseases by the vitamin D endocrine system","volume":"4","author":"Adorini","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.007_bib38","first-page":"133","article-title":"Vitamin D and autoimmune disease","volume":"39","author":"Ginanjar","year":"2007","journal-title":"Acta Med Indones"},{"issue":"10","key":"10.1016\/j.det.2010.03.007_bib39","first-page":"1291","article-title":"Vitamin D deficiency in Saudi patients with systemic lupus erythematosus","volume":"30","author":"Damanhouri","year":"2009","journal-title":"Saudi Med J"},{"issue":"5","key":"10.1016\/j.det.2010.03.007_bib40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0781.2008.00373.x","article-title":"Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus","volume":"24","author":"Cusack","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1","key":"10.1016\/j.det.2010.03.007_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00467-009-1291-x","article-title":"The use of low-dose cyclophosphamide followed by AZA\/MMF treatment in childhood lupus nephritis","volume":"25","author":"Baskin","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1016\/j.det.2010.03.007_bib42","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/0961203309106892","article-title":"The Euro-Lupus nephritis trial: the development of the sequential treatment protocol","volume":"18","author":"D'Cruz","year":"2009","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.det.2010.03.007_bib43","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/0961203309106921","article-title":"Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside","volume":"18","author":"Zandman-Goddard","year":"2009","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.det.2010.03.007_bib44","doi-asserted-by":"crossref","first-page":"R182","DOI":"10.1186\/ar2093","article-title":"Systematic review and meta-analysis of randomized trials and cohort studies of mycophenolate mofetil in lupus nephritis","volume":"8","author":"Moore","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.det.2010.03.007_bib45","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1053\/j.ajkd.2008.03.036","article-title":"Complete remission of Lupus Nephritis with Rituximab and steroids for induction and Rituximab alone for maintenance therapy","volume":"52","author":"Camous","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.det.2010.03.007_bib46","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/0961203309106174","article-title":"Rituximab in systemic lupus erythematosus: a systematic review of off-label use in 188 cases","volume":"18","author":"Ramos-Casals","year":"2009","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.det.2010.03.007_bib48","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/art.24699","article-title":"A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus","volume":"61","author":"Wallace","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.det.2010.03.007_bib49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/ar2711","article-title":"Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects","volume":"11","author":"Monneaux","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.det.2010.03.007_bib50","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/ar1942","article-title":"Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus","volume":"8","author":"D\u00f2rner","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.det.2010.03.007_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10165-009-0213-x","article-title":"A perspective on B-cell-targeting therapy for SLE","volume":"20","author":"Looney","year":"2010","journal-title":"Mod Rheumatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T20:54:51Z","timestamp":1544475291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863510000483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0733863510000483"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2010.03.007","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}